Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Ingavirin

Generic Name: Ingavirin

Drug Type: Small Molecule

Chemical Formula: C_₁₀H_₁₅N_₃O_₃

CAS Number: 219694-63-0

Unique Ingredient Identifier: 3CM03MUJ69

Overview

Ingavirin has been used in trials studying the treatment of Influenza and Common Cold.

Background

Ingavirin has been used in trials studying the treatment of Influenza and Common Cold.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections

Phase 4

Recruiting

Posted: 2024/03/18

Sponsor:Valenta Pharm JSC

ID:NCT06315400

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o.

Phase 3

Completed

Posted: 2017/07/02

Sponsor:Valenta Pharm JSC

ID:NCT03206346

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o.

Phase 3

Completed

Posted: 2017/06/19

Sponsor:Valenta Pharm JSC

ID:NCT03191097

Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections

Phase 3

Completed

Posted: 2017/06/16

Sponsor:Valenta Pharm JSC

ID:NCT03189537

Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults

Phase 4

Completed

Posted: 2017/05/16

Sponsor:Valenta Pharm JSC

ID:NCT03154515

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy